Study subjects meeting any of the following criteria will not be included in this study:
Among 901 domestic clinical trial cases up to the time of approval, 103 cases ( 11.4%) showed clinical results that included abnormalities and side effects. These mainly included hypoglycemia, nasopharyngitis, and elevated lipase.
Given the appearance of serious side effects such as hypoglycemia (0.1~5%) , administer medication in conjunction with close observation of patient status. Other DPP-4 inhibitors have been reported to present serious hypoglycemia in combination with Sulfonylurea medications as well as some cases of loss of consciousness. Moreover, decreased blood sugar from the use of this medication, once confirmed, can be remedied by giving sucrose. However, hypoglycemia resulting from a combination with glucosidase inhibitors should be treated with fructose.
(provide cautious dosage to the following patients): The following patients or circumstances
OrioPharma is one of the leading and most reputed finished pharmaceutical products suppliers in Bangladesh. We guarantee that our products are 100% genuine.
Copyright © 2023. All rights reserved.